| CKD | chronic kidney disease |
| CKD-MBD | mineral ad bone disorders of chronic kidney disease |
| CV | cardiovascular |
| CVD | cardiovascular disease |
| DKD | diabetic kidney disease |
| ECM | extracelular matrix |
| ESRD | end-stage renal disease |
| FGF | fibroblast growth factor |
| GFR | glomerular filtration rate |
| GI | gastrointestinal tract |
| GLP1 | glucagon-like peptide 1 |
| HOMA-IR | Homeostatic Model Assessment for Insulin Resistance |
| IGF1 | insulin-like growth fatcor 1 |
| IL | interleukin |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| KEEP | Kidney Early Evaluation Program |
| MDRD | Modification of Diet in Renal Disease |
| NHE3 | sodium-hydrogen exchanger3 |
| NHANES | National Health and Nutrition Examination Survey |
| PTH | parathyroid hormone |
| SGLT2i | sodium-glucose co-transporter type 1 |
| sFRp-4 | soluble Frizzled-related protein 4 |
| T2D | type 2 diabetes |
| VSMC | vascular smooth muscle cells |